EU Investigates Teva For Undermining Copaxone Generics
Case Puts Recent EU Antitrust Rulings Into the Spotlight
The European Commission is investigating whether Teva “abusively” blocked or delayed market entry of competitors to the company’s top selling multiple sclerosis drug.
